- P-ISSN 1010-0695
- E-ISSN 2288-3339
Objectives: This case report is presented to introduce the effectiveness of herbal decoction on patients with alcoholic liver disease. Methods: We closely observed two patients who were admitted in the Department of Internal Medicine Department 1 of Kyung Hee Oriental Medicine Hospital due to alcoholic liver disease. We gave herbal decoction to these patients and then analyzed the changes in their general conditions as well as blood test results. Results and Conclusions: The treatments with herbal decoctions Cheongganhaeju-tang and Injincheonggan-tang were helpful for ALD patients. Conclusions: To provide more qualified medical service in the TKMH, they will be required to increase the proportion of non medical doctor employees, like Western medicine counterparts.
1. Fauci. Harrison's Principles of Internal Medicine. 17th. USA: McGraw-hill. 2010:6177-6184.
2. National Statistical Office Social Statistics Department. Statistics of death and the cause of death in 2009. Seoul:National Statistical Office. 2010:24
3. National Health Insurance Corporation. The gender ratio and age specific percentage of ALD in 2009. Available fromURL:http://stat.mw.go. kr/stat/data/cm_data_view.jsp?menu_code=MN0 3020000&cont_seq=16550
4. Jeon DW. Non-alcoholic fatty liver disease. The Korean Journal of Hepatology. 2011;17(3s):332- 336.
5. Suk KT, Baik SK, Yoon JH, Heong JY, Paik YH, Lee CH, et al. Revision and update clinical practice guideline for liver cirrhosis. The Korean Journal of Hepatology. 2012;18;1-21.
6. Janca A, Hiller W. ICD-10 checklists-a tool for clinicians' use of the ICD-10 classification of mental and behavioral disorders. Compr Psychiatry. 1996;37(3):180-187
7. Selzer ML. The Michigan alcoholism screening test-the quest for a newdiagnostic instrument. Am J Psychiatry. 1971;127(12):1653-1658.
8. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT)-WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction. 1993;88(6):791-804.
9. Ewing JA. Detecting alcoholism-The CAGE questionnaire. JAMA. 1984;252(14):1905-1907.
10. Kaplositz N, Than TA, Shinogara M, Ji C. Endoplasmic reticulum stress and liver injury. Semin Liver Dis. 2007;27(4):367-377.
11. Lieber CS. Biochemical factors in alcoholic liver disease. Semin Liver Dis. 1993;13(2):136-153
12. O'Shea RS, Dasarathy S, McCullough AJ. Practice Guideline Committee of the American Association for the Study of Liver diseases. Hepatology. 2010;51(1):307-328.
13. Schenker S, Halff GA. Nutritional therapy in alcoholic liver disease. Semin Liver Dis. 1993; 13(2):196-209.
14. KoreanMedicine College Hepatology faculty. Hepato-internal medicine. Seoul: Dongyang medical publish company. 2001;256,286-90.
15. Jangjungkyung. Treatise on Cold-induced Diseases. Seoul: Haneumunwhasa. 2005:395
16. Lee JH. The Effect of Chungganhaeju-tang on TGF- 1-induced Hepatic β Fibrosis. Korean J. Orient.Int.Med. 2005;16(1):93-106.
17. Lee HI. Inhibitory Effect of Injinchunggan-tang on Fibrogenesis of Rat Hepatic Stellate Cells. Korean J. Orient.Int.Med. 2009;30(1):74-84.
18. Han CW. The Effects of Chungganhaeju-tang on NFκB Activation and Apoptosis of Kupffer Cells. Korean J. Orient.Int.Med. 2004;25(1): 59-70.
19. Yoon YK. The Effects of Chungganhaeju-tang on glutathione synthesis in HepG2 cell. Korean J. Orient.Int.Med. 2004;25(1):81-91.
20. Kim YT. Effects of Chungganhaeju-tangon Gene Expression of Alcohol-metabolizing Enzymes and Alcohol-induced Apoptosis. Korean J. Orient.Int.Med. 2003;24(1):123-133.
21. Lee JH. The effects of Injinchunggan-tang on Interferon Signaling Pathway of HepG2 cells. Korean J. Orient.Int.Med. 200526(1):74-92.
22. Kim JK. The Effects of Injinchunggan-tang on Inflammatory Cytokine Gene Expression in Kupffer Cells. Korean J. Orient.Int.Med. 2004; 25(1):46-58.